Ningning Xu
10Patents
3h-index
53Co-inventors
59Inventor score
Filing activity: Sep 8, 2005 → Oct 11, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8377980B2 | Hepatitis C virus inhibitors | Chemistry; Metallurgy | 21 | Active |
| US9850225B2 | Compounds useful as immunomodulators | Emerging Cross-Sectional Technologies | 11 | Active |
| US9326973B2 | Hepatitis C virus inhibitors | Chemistry; Metallurgy | 8 | Active |
| US8796466B2 | Hepatitis C virus inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10745382B2 | Compounds useful as immunomodulators | Emerging Cross-Sectional Technologies | 2 | Active |
| US7566785B2 | Amidine substituted aryl aniline compounds | Chemistry; Metallurgy | 1 | Active |
| US9102599B2 | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases | Chemistry; Metallurgy | 0 | Active |
| US10617675B2 | Hepatitis C virus inhibitors | Human Necessities | 0 | Active |
| US8404896B2 | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases | Chemistry; Metallurgy | 0 | Active |
| US9770439B2 | Hepatitis C virus inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.